While the receptor for CCL3 and CCL5, CCR5, is not commonly expressed in PBMCs of RA patients, it has been found to be highly expressed in the RA synovium, either due to an upregulation of expression, increase in CCR5+ cells in the synovium, or an interplay of both (159). The gene discussed is CCL5; the disease is rheumatoid arthritis.